Mycobacterium xenopi

Last updated on: 21.02.2023

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

M. xenopi is detected in tap water and is therefore of no clinical relevance in most cases, but can cause pulmonary infections in other underlying diseases (Varadi RG et al. 2009).

Dosage and method of useThis section has been translated automatically.

Although a variety of drugs are tested sensitively in resistance testing of M. xenopi (RMP, clarithromycin, fluoroquinolones, PTH; variable in INH and EMB), there is no confirmed effective therapy (Varadi RG et al. 2009).

For disease caused by M. xenopi, ATS/IDSA recommend the same triple combination as for M. avium, but isoniazid is considered quite effective in vivo, similar to the ratios for M. kansasii (Griffith DE et al. 2007).

LiteratureThis section has been translated automatically.

  1. Griffith DE et al (2007) Am J Respir Crit Care Med 175: 367-416.
  2. Saliba J et al (2021) A Rare Case of Henoch-Schönlein Purpura and Mycobacterium xenopi Pulmonary Infection. Cureus 13:e13533.
  3. Varadi RG et al (2009) Pulmonary Mycobacterium xenopi infection in non-HIV-infected patients: a systematic review. Int J Tuberc Lung Dis 13: 1210-1218.

Last updated on: 21.02.2023